The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Melbourne-based drug delivery technology company, Phosphagenics, is going to launch phase I study of a transd...
Singapore:Â Australian schoolboys have begun receiving the first-of-three vaccinations to protect them against cancers...
Singapore: Patrys has received approval to commence its planned phase I/IIa multiple myeloma trial with lead anti-...
Singapore: AtCor Medical, the developer and marketer of the SphygmoCor system that measures central aortic blood pressur...
Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has d...
Singapore: The bioscience industry in the major markets of Asia-Pacific region, excluding Japan and comprising Australia...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore:Â ImmusanT initiated clinical trials in New Zealand, Australia and the US to evaluate Nexvax2, the first the...
Singapore: Ministerial Advisory Committee on HIV/AIDS (MAC) in Australia has achieved 15 percent reduction in HIV notifi...
Singapore:Â Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical t...
Singapore: A clinical drug for Huntington's and Alzheimer's disease by Australia-based Prana Biotechnology, a global dev...
Singapore: Australia Minister for Health, Ms Tanya Plibersek, announced that $652 million will be provided for 1,141 gra...
Singapore: Australian vaccine development company BioDiem announced that it has begun research collaboration with France...
Singapore: Australia-based AtCor Medical, the developer and marketer of the SphygmoCor system which measures central aor...
Singapore: How far will a drug company go to fund drug discovery and development? Melborne-based biotechnology company A...
Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its U...
Singapore: Dr Deborah Rathjen, CEO of Australia based Bionomics, was awarded the Life Science Woman Executive of the Yea...
A company that has been leveraging on drug delivery products is Alchemia. Its HyACT technology uses hyaluronic acid's (H...
Singapore: Pfizer will make a phased exit of its West Ryde plant in Australia, which produces tablets and capsules for b...
Singapore: BioDiem received a grant of a Chinese divisional patent, expanding the patent position for its novel antimicr...
Singapore: AusBiotech has appointed Mr Lawrence Gozlan as a non-executive director to its board. He has experience in gl...
Singapore:Â Vaxxas, a UniQuest start-up established in 2011 to commercialize the Nanopatch vaccine delivery system bas...
Singapore: Dr Deborah Rathjen, managing director of Bionomics and chair of AusBiotech, has been elected as the chair of ...
Singapore: Australian drug delivery company, Phosphagenics, has received regulatory nod to commence proof of concept of ...
